Risk of Late Relapse or Reinfection With Hepatitis C Virus After Achieving a Sustained Virological Response: A Systematic Review and Meta-analysis (Q28076352)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Risk of Late Relapse or Reinfection With Hepatitis C Virus After Achieving a Sustained Virological Response: A Systematic Review and Meta-analysis	scientific article

Statements

scholarly article

1 reference

3 references

20 July 2020

25 October 2022

26 October 2022

systematic review

1 reference

PubMed publication ID

1 reference

PubMed publication ID

Risk of Late Relapse or Reinfection With Hepatitis C Virus After Achieving a Sustained Virological Response: A Systematic Review and Meta-analysis (English)

1 reference

1 reference

20 July 2020

chronic hepatitis C

1 reference

20 July 2020

Hepatitis C virus

1 reference

based on heuristic

inferred from title

sustained virologic response

1 reference

PubMed publication ID

systematic review

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26787172%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

Richard D. Riley

4

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26787172%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

author name string

Jawaad Saleem

2

2 references

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26787172%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

Andrew Hill

3

2 references

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26787172%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

Graham S Cooke

5

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26787172%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

language of work or name

1 reference

publication date

15 March 2016

7 references

23 March 2019

21 March 2019

1 July 2020

20 July 2020

25 October 2022

26 October 2022

Clinical Infectious Diseases

8 references

23 March 2019

21 March 2019

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26787172%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

1 July 2020

20 July 2020

25 October 2022

26 October 2022

62

2 references

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26787172%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

6

2 references

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26787172%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

683-694

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26787172%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

copyright license

Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International

1 reference

PMC publication ID

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4772843

20 March 2017

Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4772843

20 March 2017

Global epidemiology of hepatitis B and hepatitis C in people who inject drugs: results of systematic reviews

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4772843

20 March 2017

Clinical, virologic, histologic, and biochemical outcomes after successful HCV therapy: A 5-year follow-up of 150 patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4772843

20 March 2017

Global epidemiology of hepatitis C virus infection

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4772843

20 March 2017

High versus standard doses interferon-alpha in the treatment of naïve chronic hepatitis C patients in Taiwan: a 10-year cohort study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4772843

20 March 2017

Meta-analysis in clinical trials

2 references

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4772843

20 March 2017

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4772843

29 September 2017

Peginterferon Alfa-2a plus ribavirin for chronic hepatitis C virus infection in HIV-infected patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4772843

20 March 2017

Global epidemiology of hepatitis C virus infection: new estimates of age-specific antibody to HCV seroprevalence

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4772843

7 April 2017

Long-Term Treatment Outcomes of Patients Infected With Hepatitis C Virus: A Systematic Review and Meta-analysis of the Survival Benefit of Achieving a Sustained Virological Response

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4772843

29 September 2017

Metaprop: a Stata command to perform meta-analysis of binomial data

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4772843

29 September 2017

Long-term follow-up of patients receiving boceprevir for treatment of chronic hepatitis C.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4772843

29 September 2017

Historical epidemiology of hepatitis C virus (HCV) in selected countries.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4772843

29 September 2017

Sequence analysis of hepatitis C virus from patients with relapse after a sustained virological response: relapse or reinfection?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4772843

29 September 2017

Durability of sustained virologic response in chronic hepatitis C.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4772843

29 September 2017

Viral hepatitis in resource-limited countries and access to antiviral therapies: current and future challenges.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4772843

29 September 2017

Long-term outcome of chronic hepatitis C after sustained virological response to interferon-based therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4772843

29 September 2017

Prognosis research strategy (PROGRESS) 1: a framework for researching clinical outcomes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4772843

29 September 2017

Longitudinal changes of the laboratory data of chronic hepatitis C patients with sustained virological response on long-term follow-up

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4772843

29 September 2017

Durability of a sustained virological response in chronic hepatitis C patients treated with pegylated interferon alfa and ribavirin

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4772843

29 September 2017

Sustained virologic response to antiviral therapy for chronic hepatitis C virus infection: a cure and so much more

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4772843

29 September 2017

Long-term outcome of chronic hepatitis C patients with sustained virological response to peginterferon plus ribavirin

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4772843

29 September 2017

Sustained virologic response among Latino veterans; does it represent the cure of chronic hepatitis C infection?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4772843

29 September 2017

Outcome of sustained virological responders with histologically advanced chronic hepatitis C.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4772843

29 September 2017

Estimation of stage-specific fibrosis progression rates in chronic hepatitis C virus infection: a meta-analysis and meta-regression

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4772843

29 September 2017

Long-term outcomes of chronic hepatitis C patients with sustained virological response at 6 months after the end of treatment

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4772843

29 September 2017

Long term clinical outcome of chronic hepatitis C patients with sustained virological response to interferon monotherapy.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4772843

29 September 2017

Sustained virological response after treatment in patients with chronic hepatitis C infection--a five year follow up.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4772843

2 June 2018

Long-term clearance of hepatitis C virus following interferon α-2b or peginterferon α-2b, alone or in combination with ribavirin.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4772843

2 June 2018

Durability of the response to peginterferon-α2b and ribavirin in patients with chronic hepatitis C: a cohort study in the routine clinical setting.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4772843

2 June 2018

Long-term evolution of serum and liver viral markers in patients treated for chronic hepatitis C and sustained response

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4772843

2 June 2018

Acute hepatitis C: high rate of both spontaneous and treatment-induced viral clearance.

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIV948

21 January 2018

Rate and timing of hepatitis C virus relapse after a successful course of pegylated interferon plus ribavirin in HIV-infected and HIV-uninfected patients

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIV948

21 January 2018

Long-term follow-up of chronic hepatitis C patients with sustained virological response to various forms of interferon-based anti-viral therapy

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIV948

21 January 2018

Why add anything to nothing? The arcsine difference as a measure of treatment effect in meta-analysis with zero cells

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIV948

21 January 2018

Sustained virologic response after therapy with the HCV protease inhibitor narlaprevir in combination with peginterferon and ribavirin is durable through long-term follow-up.

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIV948

21 January 2018

Durability of a sustained virological response, late clinical sequelae, and long-term changes in aspartate aminotransferase to the platelet ratio index after successful treatment with peginterferon/ribavirin for chronic hepatitis C: a prospective st

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIV948

21 January 2018

Durability of SVR in chronic hepatitis C patients treated with peginterferon-α2a/ribavirin in combination with a direct-acting anti-viral

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIV948

21 January 2018

Sustained virological response to pegylated interferon and ribavirin is maintained during long-term follow-up of chronic hepatitis C patients.

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIV948

21 January 2018

How sustained is sustained viral response in patients with hepatitis C virus infection?

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIV948

21 January 2018

A sustained virologic response is durable in patients with chronic hepatitis C treated with peginterferon alfa-2a and ribavirin

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIV948

21 January 2018

Durability of a sustained virologic response in combination therapy with interferon/peginterferon and ribavirin for chronic hepatitis C

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIV948

21 January 2018

Eradication of hepatitis C virus in patients successfully treated for chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIV948

21 January 2018

Long-term follow-up of previous hepatitis C virus positive nonresponders to interferon monotherapy successfully retreated with combination therapy: are they really cured?

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIV948

21 January 2018

Sustained virological response rates and durability of the response to interferon-based therapies in hepatitis C patients treated in the clinical setting

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIV948

21 January 2018

Late relapse in chronic hepatitis C after sustained viral response to interferon and ribavirin

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIV948

21 January 2018

Long-term clinical and virological outcomes of chronic hepatitis C after successful interferon therapy

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIV948

21 January 2018

[Long-term assessment of relapse and associated risk factors in chronic hepatitis C patients treated with interferon and ribavirin].

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4772843

27 November 2018

Durability of sustained virologic response in chronic hepatitis C: analysis of factors related to relapse after sustained virologic response with peginterferon plus ribavirin combination therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4772843

27 November 2018

Five-year follow-up of patients with chronic C hepatitis and sustained virological response.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4772843

27 November 2018

Long-term follow-up of patients with chronic hepatitis C with sustained virologic response to interferon.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4772843

27 November 2018

[Long-term viral response to interferon alpha 2b plus ribavirin in chronic hepatitis C patients during standard therapy].

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4772843

27 November 2018

Long-term response to interferon plus ribavirin in patients with chronic hepatitis C refractory to interferon.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4772843

27 November 2018

Identifiers

10.1093/CID/CIV948

2 references

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26787172%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

OpenCitations bibliographic resource ID

1 reference

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

PMC publication ID

2 references

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26787172%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

PubMed publication ID

2 references

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26787172%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q28076352&oldid=1758575918"